Viewing Study NCT02591095


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-01-04 @ 4:39 PM
Study NCT ID: NCT02591095
Status: COMPLETED
Last Update Posted: 2019-03-19
First Post: 2015-10-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Sponsor: Centre Francois Baclesse
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module